BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 36964642)

  • 1. Reinfections from SARS-CoV-2: A Retrospective Study from the Gyncentrum Genetic Laboratory in Sosnowiec, Poland, April 2020 to July 2022.
    Morawiec E; Bednarska-Czerwińska A; Pudełko A; Zmarzły N; Rojczyk E; Madej K; Sobański D; Staszkiewicz R; Ossowski P; Boroń-Kaczmarska A; Zapletal-Pudełko K; Boroń D; Grabarek BO
    Med Sci Monit; 2023 Mar; 29():e939452. PubMed ID: 36964642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence, Risk, and Severity of SARS-CoV-2 Reinfections in Children and Adolescents Between March 2020 and July 2022 in Serbia.
    Medic S; Anastassopoulou C; Lozanov-Crvenkovic Z; Dragnic N; Petrovic V; Ristic M; Pustahija T; Tsakris A; Ioannidis JPA
    JAMA Netw Open; 2023 Feb; 6(2):e2255779. PubMed ID: 36780157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020.
    Lee JT; Hesse EM; Paulin HN; Datta D; Katz LS; Talwar A; Chang G; Galang RR; Harcourt JL; Tamin A; Thornburg NJ; Wong KK; Stevens V; Kim K; Tong S; Zhou B; Queen K; Drobeniuc J; Folster JM; Sexton DJ; Ramachandran S; Browne H; Iskander J; Mitruka K
    Clin Infect Dis; 2021 Dec; 73(12):2217-2225. PubMed ID: 33598716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of reinfections after SARS-CoV-2 primary infection in the population of an Italian province: a cohort study.
    Flacco ME; Acuti Martellucci C; Soldato G; Carota R; Fazii P; Caponetti A; Manzoli L
    J Public Health (Oxf); 2022 Dec; 44(4):e475-e478. PubMed ID: 34492110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study.
    Jang EJ; Choe YJ; Yun GW; Wang S; Cho UJ; Yi S; Lee S; Park YJ
    J Med Virol; 2022 Nov; 94(11):5589-5592. PubMed ID: 35879105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Longitudinal Monitoring of Seroconversion Status in SARS-CoV-2 RT-PCR Positive Healthcare Workers].
    Ersoy L; Tezcan Ülger S; Gülbudak H; Yaşar N; Yapıcı G; Aslan G
    Mikrobiyol Bul; 2022 Jan; 56(1):114-123. PubMed ID: 35088965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate and severity of suspected SARS-Cov-2 reinfection in a cohort of PCR-positive COVID-19 patients.
    Slezak J; Bruxvoort K; Fischer H; Broder B; Ackerson B; Tartof S
    Clin Microbiol Infect; 2021 Dec; 27(12):1860.e7-1860.e10. PubMed ID: 34419576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Reinfection Rate and Outcomes in Saudi Arabia: A National Retrospective Study.
    Al-Otaiby M; Krissaane I; Al Seraihi A; Alshenaifi J; Qahtani MH; Aljeri T; Zaatari E; Hassanain M; Algwizani A; Albarrag A; Al-Mozaini M; Alabdulaali M
    Int J Infect Dis; 2022 Sep; 122():758-766. PubMed ID: 35840098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Retrospective Population Study of 385 191 Positive Real-Time Reverse Transcription-Polymerase Chain Reaction Tests For SARS-CoV-2 from a Single Laboratory in Katowice, Poland from April 2020 to July 2022.
    Morawiec E; Bednarska-Czerwińska A; Pudełko A; Strychalska A; Broncel M; Sagan D; Madej A; Jasińska-Balwierz A; Staszkiewicz R; Sobański D; Boroń D; Pokusa F; Grabarek B
    Med Sci Monit; 2023 Jan; 29():e938872. PubMed ID: 36636983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of SARS-CoV-2 reinfections in children: a prospective national surveillance study between January, 2020, and July, 2021, in England.
    Mensah AA; Campbell H; Stowe J; Seghezzo G; Simmons R; Lacy J; Bukasa A; O'Boyle S; Ramsay ME; Brown K; Ladhani SN
    Lancet Child Adolesc Health; 2022 Jun; 6(6):384-392. PubMed ID: 35358491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.
    Bøås H; Storm ML; Tapia G; Kristoffersen AB; Løvlie AL; Størdal K; Lyngstad TM; Bragstad K; Hungnes O; Veneti L
    BMC Public Health; 2024 Jan; 24(1):181. PubMed ID: 38225588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 reinfections in the pediatric cohort-a single-center experience.
    Arslan A; Sahbudak Bal Z; Erci E; Yıldırım Arslan S; Bilen NM; Avcu G; Çiçek C; Ozkinay F; Kurugol Z
    J Trop Pediatr; 2023 Dec; 70(1):. PubMed ID: 38150674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador.
    Guevara R; Prado-Vivar B; Márquez S; Muñoz EB; Carvajal M; Guadalupe JJ; Becerra-Wong M; Proaño S; Bayas-Rea R; Coloma J; Grunauer M; Trueba G; Rojas-Silva P; Barragán V; Cárdenas P
    Front Cell Infect Microbiol; 2022; 12():951383. PubMed ID: 36164552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study.
    Nielsen KF; Moustsen-Helms IR; Schelde AB; Gram MA; Emborg HD; Nielsen J; Hansen CH; Andersen MA; Meaidi M; Wohlfahrt J; Valentiner-Branth P
    PLoS Med; 2022 Nov; 19(11):e1004037. PubMed ID: 36413551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting.
    Abu-Raddad LJ; Chemaitelly H; Malek JA; Ahmed AA; Mohamoud YA; Younuskunju S; Ayoub HH; Al Kanaani Z; Al Khal A; Al Kuwari E; Butt AA; Coyle P; Jeremijenko A; Kaleeckal AH; Latif AN; Shaik RM; Abdul Rahim HF; Yassine HM; Al Kuwari MG; Al Romaihi HE; Al-Thani MH; Bertollini R
    Clin Infect Dis; 2021 Oct; 73(7):e1830-e1840. PubMed ID: 33315061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.
    Lacy J; Mensah A; Simmons R; Andrews N; Siddiqui MR; Bukasa A; O'Boyle S; Campbell H; Brown K
    Epidemiol Infect; 2022 May; 150():e109. PubMed ID: 35607808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2 reinfection and COVID-19 severity.
    Nguyen NN; Houhamdi L; Hoang VT; Delerce J; Delorme L; Colson P; Brouqui P; Fournier PE; Raoult D; Gautret P
    Emerg Microbes Infect; 2022 Dec; 11(1):894-901. PubMed ID: 35264078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing Severe Acute Respiratory Syndrome Coronavirus 2 Persistence and Reinfection: A Retrospective Cohort Study.
    Turbett SE; Tomkins-Tinch CH; Anahtar MN; Dugdale CM; Hyle EP; Shenoy ES; Shaw B; Egbuonu K; Bowman KA; Zachary KC; Adams GC; Hooper DC; Ryan ET; LaRocque RC; Bassett IV; Triant VA; Siddle KJ; Rosenberg E; Sabeti PC; Schaffner SF; MacInnis BL; Lemieux JE; Charles RC
    Clin Infect Dis; 2023 Mar; 76(5):850-860. PubMed ID: 36268576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced Odds of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Vaccination Among New York City Adults, July 2021-November 2021.
    Levin-Rector A; Firestein L; McGibbon E; Sell J; Lim S; Lee EH; Weiss D; Geevarughese A; Zucker JR; Greene SK
    Clin Infect Dis; 2023 Feb; 76(3):e469-e476. PubMed ID: 35594552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Naturally Acquired Immunity versus Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: A Retrospective Cohort Study.
    Gazit S; Shlezinger R; Perez G; Lotan R; Peretz A; Ben-Tov A; Herzel E; Alapi H; Cohen D; Muhsen K; Chodick G; Patalon T
    Clin Infect Dis; 2022 Aug; 75(1):e545-e551. PubMed ID: 35380632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.